Convenient Synthesis of Some New Thiophene, Pyrazole, and Thiazole Derivatives Bearing Biologically Active Sulfonyl Guanidine Moiety

References

• M. H. Helal, S. Y. Abbas, M. A. Salem, A. A. Farag, and Y. A. Ammar, “Synthesis and Characterization of New Types of 2-(6-Methoxy-2-Naphthyl) Propionamide Derivatives as Potential Antibacterial and Antifungal Agents,” Medicinal Chemistry Research 22, no. 11 (2013): 5598–609.
   Web of Science ®Google Scholar
• Samir Y. Abbas, Marwa A. M. Sh. El-Sharief, Wahid M. Basyouni, Issa M. I. Fakhr, and Eman W. El-Gammal, “El-Gammal EW: Thiourea Derivatives Incorporating a Hippuric Acid Moiety: Synthesis and Evaluation of Antibacterial and Antifungal Activities,” European Journal of Medicinal Chemistry 64 (2013): 111–20.
   PubMed Web of Science ®Google Scholar
• M. A. M. S. El-Sharief, S. Y. Abbas, K. A. M. El-Bayouki, and E. W. El-Gammal, “Synthesis of Thiosemicarbazones Derived from N-(4-Hippuric Acid)Thiosemicarbazide and Different Carbonyl Compounds as Antimicrobial Agents,” European Journal of Medicinal Chemistry 67 (2013): 263–8.
   PubMed Web of Science ®Google Scholar
• P. Kumar, B. Narasimhan, and D. Sharma, “Substituted Benzoic Acid Benzylidene/Furan-2-yl-Methylene Hydrazides: Synthesis, Antimicrobial Evaluation and QSAR Analysis,” Arkivoc 2008, no. 13 (2008): 159–78.
   Google Scholar
• H. Mitsuya, R. Yarchoan, and S. Broder, “Molecular Targets for AIDS Therapy,” Science (New York, N.Y.) 249, no. 4976 (1990): 1533–44.
   PubMed Web of Science ®Google Scholar
• P.-L. Shao, L.-M. Huang, and P.-R. Hsueh, “Recent Advances and Challenges in the Treatment of Invasive Fungal Infections,” International Journal of Antimicrobial Agents 30, no. 6 (2007): 487–95.
   PubMed Web of Science ®Google Scholar
• Ian Chopra, Christopher Schofield, Martin Everett, Alex O'Neill, Keith Miller, Mark Wilcox, Jean-Marie Frère, Mike Dawson, Lloyd Czaplewski, Uros Urleb, et al. “Treatment of Health-Care-Associated Infections Caused by Gram-Negative Bacteria: A Consensus Statement,” The Lancet. Infectious Diseases 8, no. 2 (2008): 133–9.
   PubMed Web of Science ®Google Scholar
• S. A. Hessein, M. A. M. S. El-Sharief, S. Y. Abbas, H. K. Thabet, and Y. A. Ammar, “Synthesis and Antimicrobial Activity of Furochromone, Benzofuran and Furocoumarin Derivatives Bearing Sulfonyl Moiety,” Croatica Chemica Acta 89, no. 1 (2016): 91–100.
   Web of Science ®Google Scholar
• C. R. Mizdal, S. T. Stefanello, P. A. Nogara, F. A. A. Soares, L. de Lourenço Marques, and M. M. A. de Campos, “Molecular Docking, and anti-Biofilm Activity of Gold-Complexed Sulfonamides on Pseudomonas aeruginosa,” Microbial Pathogenesis 125 (2018): 393–400.
   PubMed Web of Science ®Google Scholar
• H. S. Mohamed, M. E. Haiba, N. A. Mohamed, G. E. A. Awad, and N. S. Ahmed, “New Hydronaphthalene-Sulfonamide Derivatives: Synthesis, Antimicrobial Evaluation and QSAR Study,” Journal of Molecular Structure 1246 (2021): 131108.
   Web of Science ®Google Scholar
• A. A. Fadda, M. M. Mukhtar, and H. M. Refat, “Utility of Activated Nitriles in the Synthesis of Some New Heterocyclic Compounds,” American Journal of Organic Chemistry 2, no. 2 (2012): 32–40.
   Google Scholar
• J. Zhang, Y. Tan, G. Li, L. Chen, M. Nie, Z. Wang, and H. Ji, “Coumarin Sulfonamides and Amides Derivatives: Design, Synthesis, and Antitumor Activity in Vitro,” Molecules 26, no. 4 (2021): 786.
   PubMed Web of Science ®Google Scholar
• N. Kausar, S. Muratza, M. A. Raza, H. Rafique, M. N. Arshad, A. A. Altaf, A. M. Asiri, S. S. Shafqat, and S. R. Shafqat, “Sulfonamide Hybrid Schiff Bases of Anthranilic Acid: Synthesis, Characterization and Their Biological Potential,” Journal of Molecular Structure 1185 (2019): 8–20.
   Web of Science ®Google Scholar
• Lina Fernanda Castaño, Viviana Cuartas, Anthony Bernal, Alberto Insuasty, Juan Guzman, Oscar Vidal, Vivian Rubio, Gloria Puerto, Pavol Lukáč, Vladimir Vimberg, et al. “New Chalcone-Sulfonamide Hybrids Exhibiting Anticancer and Antituberculosis Activity,” European Journal of Medicinal Chemistry 176 (2019): 50–60.
   PubMed Web of Science ®Google Scholar
• J. J. Li, G. D. Anderson, E. G. Burton, J. N. Cogburn, J. T. Collins, D. J. Garland, S. A. Gregory, H. C. Huang, P. C. Isakson, and C. M. Koboldt, “ 1,2-Diarylcyclopentenes as Selective Cyclooxygenase-2 Inhibitors and Orally Active Anti-inflammatory Agents,” Journal of Medicinal Chemistry 38, no. 22 (1995): 4570–8.
   PubMed Web of Science ®Google Scholar
• C. Camoutsis, A. Geronikaki, A. Ciric, M. Soković, P. Zoumpoulakis, and M. Zervou, “Sulfonamide-1,2,4-Thiadiazole Derivatives as Antifungal and Antibacterial Agents: Synthesis, Biological Evaluation, Lipophilicity, and Conformational Studies,” Chemical & Pharmaceutical Bulletin 58, no. 2 (2010): 160–7.
   PubMed Web of Science ®Google Scholar
• L. Bouissane, S. El Kazzouli, S. Léonce, B. Pfeiffer, E. M. Rakib, M. Khouili, and G. Guillaumet, “Synthesis and Biological Evaluation of N-(7-indazolyl)benzenesulfonamide derivatives as potent cell cycle inhibitors,” Bioorganic & Medicinal Chemistry 14, no. 4 (2006): 1078–88.
   PubMed Web of Science ®Google Scholar
• M. T. Labro, “Immunomodulation by Antibacterial agents. Is it clinically relevant?,” Drugs 45, no. 3 (1993): 319–28.
   PubMed Web of Science ®Google Scholar
• C. T. Supuran, A. Scozzafava, B. C. Jurca, and M. A. Ilies, “Carbonic Anhydrase inhibitors-Part 49: Synthesis of Substituted Ureido and Thioureido Derivatives of Aromatic/Heterocyclic Sulfonamides with Increased Affinities for Isozyme I,” European Journal of Medicinal Chemistry 33, no. 2 (1998): 83–93.
   Web of Science ®Google Scholar
• S. Isik, F. Kockar, M. Aydin, O. Arslan, O. O. Guler, A. Innocenti, A. Scozzafava, and C. T. Supuran, “Carbonic Anhydrase Inhibitors: Inhibition of the Beta-Class Enzyme from the Yeast Saccharomyces Cerevisiae with Sulfonamides and Sulfamates,” Bioorganic & Medicinal Chemistry 17, no. 3 (2009): 1158–63.
   PubMed Web of Science ®Google Scholar
• M. M. Ghorab and M. S. Alsaid, “Anti-Breast Cancer Activity of Some Novel Quinoline Derivatives,” Acta Pharmaceutica (Zagreb, Croatia) 65, no. 3 (2015): 271–83.
   PubMed Web of Science ®Google Scholar
• E. S. Darwish, A. M. A. Fattah, F. A. Attaby, and O. N. Al-Shayea, “Synthesis and Antimicrobial Evaluation of Some Novel Thiazole, Pyridone, Pyrazole, Chromene, Hydrazone Derivatives Bearing a Biologically Active Sulfonamide Moiety,” International Journal of Molecular Sciences 15, no. 1 (2014): 1237–54.
   PubMed Web of Science ®Google Scholar
• A. M. Alafeefy, S. Isik, H. A. Abdel-Aziz, A. E. Ashour, D. Vullo, N. A. Al-Jaber, and C. T. Supuran, “Carbonic Anhydrase Inhibitors: Benzenesulfonamides Incorporating Cyanoacrylamide Moieties Are Low Nanomolar/Subnanomolar Inhibitors of the Tumor-Associated Isoforms IX and XII,” Bioorganic & Medicinal Chemistry 21, no. 6 (2013): 1396–403.
   PubMed Web of Science ®Google Scholar
• M. E. Azab, M. M. Youssef, and E. A. El-Bordany, “Synthesis and Antibacterial Evaluation of Novel Heterocyclic Compounds Containing a Sulfonamido Moiety,” Molecules (Basel, Switzerland) 18, no. 1 (2013): 832–44.
   PubMed Web of Science ®Google Scholar
• A. S. Salman, N. A. Mahmoud, A. Abdel-Aziem, M. A. Mohamed, and D. M. Elsisi, “Synthesis, Reactions and Antimicrobial Activity of Some New 3-Substituted Indole Derivatives,” International Journal of Organic Chemistry 05, no. 02 (2015): 81–99.
   Google Scholar
• B. P. Orner, and A. D. Hamilton, “The Guanidinium Group in Molecular Recognition: Design and Synthetic Approaches,” Journal of Inclusion Phenomena and Macrocyclic Chemistry 41, no. 1/4 (2001): 141–7.
   Web of Science ®Google Scholar
• Yang Yang, Zhijian Xu, Zhengyan Zhang, Zhuo Yang, Yingtao Liu, Jinan Wang, Tingting Cai, Shujin Li, Kaixian Chen, Jiye Shi, et al. “Like-Charge Guanidinium Pairing between Ligand and Receptor: An Unusual Interaction for Drug Discovery and Design?,” The Journal of Physical Chemistry. B 119, no. 36 (2015): 11988–97.
   PubMed Web of Science ®Google Scholar
• J. W. Liebeschuetz, R. B. Katz, A. D. Duriatti, and M. L. Arnold, “Rationally Designed Guanidine and Amidine Fungicides,” Pesticide Science 50, no. 3 (1997): 258–74.
   Google Scholar
• P. Liang, S. Shen, Q. Xu, S. Wang, S. Jin, H. Lu, Y. Dong, and J. Zhang, “Design, Synthesis Biological Activity, and Docking of Novel Fluopyram Derivatives Containing Guanidine Group,” Bioorganic & Medicinal Chemistry 29 (2021): 115846.
   PubMedGoogle Scholar
• S.-H. Kim, D. Semenya, and D. Castagnolo, “Antimicrobial Drugs Bearing Guanidine Moieties: A Review,” European Journal of Medicinal Chemistry 216 (2021): 113293.
   PubMed Web of Science ®Google Scholar
• F. Drozdov and V. Kotovb. "Guanidine: A Simple Molecule with Great Potential: From Catalysts to Biocides and Molecular Glues." Journal of Nesmeyanov Institute of Organoelement Compounds of the Russian Academy of Sciences 3, no. 6 (2020): 200–213.
   Google Scholar
• S. Ali, M. H. H. B. Asad, F. Khan, G. Murtaza, A. A. Rizvanov, J. Iqbal, B. Babak, and I. Hussain, “Biological Evaluation of Newly Synthesized Biaryl Guanidine Derivatives to Arrest β-Secretase Enzymatic Activity Involved in Alzheimer’s Disease,” BioMed Research International 2020 (2020): 1–11.
   Web of Science ®Google Scholar
• S. M. Gomha, T. A. Salah, and A. O. Abdelhamid, “Synthesis, Characterization, and Pharmacological Evaluation of Some Novel Thiadiazoles and Thiazoles Incorporating Pyrazole Moiety as Anticancer Agents,” Monatshefte Für Chemie - Chemical Monthly 146, no. 1 (2015): 149–58.
   Google Scholar
• Sobhi Gomha, Khaled Khalil, Hassan Abdel-Aziz, and Mohamed Abdalla, “Synthesis and anti-Hypertensive α-Blocking Activity Evaluation of Thiazole Derivatives Bearing Pyrazole Moiety,” Heterocycles 91, no. 9 (2015): 1763–73.
   Web of Science ®Google Scholar
• M. A. Abdallah, S. M. Gomha, and M. R. Abdelaziz, “Eldin Serag NS: Synthesis of Some Novel Thiadiazoles and Thiazoles Linked to Pyrazole Ring,” Heterocycles 92, no. 4 (2016): 649–63.
   Web of Science ®Google Scholar
• Magda Abdalla, Sobhi Gomha, Mohamad Abd EL-Aziz, and Nany Serag, “Synthesis and Evaluation of Some Novel Thiazoles and 1, 3-Thiazines as Potent Agents against the Rabies Virus,” Turkish Journal of Chemistry 40, no. 3 (2016): 441–53.
   Web of Science ®Google Scholar
• M. A. Abdallah, S. M. Gomha, I. M. Abbas, M. S. H. Kazem, S. S. Alterary, and Y. N. Mabkhot, “An Efficient Synthesis of Novel Pyrazole-Based Heterocycles as Potential Antitumor Agents,” Applied Sciences 7, no. 8 (2017): 785.
   Google Scholar
• S. M. Gomha and K. M. Dawood, “Synthetic Utility of Pyridinium Bromide: Synthesis and Antimicrobial Activity of Novel 2, 4, 6‐Trisubstituted Pyridines Having Pyrazole Moiety,” Journal of Heterocyclic Chemistry 54, no. 3 (2017): 1943–8.
   Web of Science ®Google Scholar
• I. M. Abbas, M. A. Abdallah, S. M. Gomha, and M. S. H. Kazem, “Synthesis and Antimicrobial Activity of Novel Azolopyrimidines and Pyrido‐Triazolo‐Pyrimidinones Incorporating Pyrazole Moiety,” Journal of Heterocyclic Chemistry 54, no. 6 (2017): 3447–57.
   Web of Science ®Google Scholar
• A. R. Sayed, S. M. Gomha, F. M. Abdelrazek, M. S. Farghaly, S. A. Hassan, and P. Metz, “Design, Efficient Synthesis and Molecular Docking of Some Novel Thiazolyl-Pyrazole Derivatives as Anticancer Agents,” BMC Chemistry 13, no. 1 (2019): 116.
   PubMed Web of Science ®Google Scholar
• G. S. Hassan, D. E. A. Rahman, E. A. Abdelmajeed, R. H. Refaey, M. A. Salem, and YMJEjomc Nissan, “New Pyrazole Derivatives: Synthesis, anti-Inflammatory Activity, Cycloxygenase Inhibition Assay and Evaluation of mPGES,” European Journal of Medicinal Chemistry 171 (2019): 332–42.
   PubMed Web of Science ®Google Scholar
• G. S. Masaret, “A New Approach for the Synthesis and Biological Activities of Novel Thiazolyl‐Pyrazole Derivatives,” ChemistrySelect 6, no. 5 (2021): 974–82.
   Web of Science ®Google Scholar
• M. A. Hosny, Y. H. Zaki, W. A. Mokbel, and A. O. Abdelhamid, “Synthesis, Characterization, Antimicrobial Activity and Anticancer of Some New Pyrazolo,” Medicinal Chemistry 16, no. 6 (2020): 750–60.
   PubMed Web of Science ®Google Scholar
• Abdou O. Abdelhamid, Ibrahim E. El Sayed, Yasser H. Zaki, Ahmed M. Hussein, Mangoud M. Mangoud, and Mona A. Hosny, “Utility of 5-(Furan-2-yl)-3-(p-Tolyl)-4, 5-Dihydro-1 H-Pyrazole-1-Carbothioamide in the Synthesis of Heterocyclic Compounds with Antimicrobial Activity,” BMC Chemistry 13, no. 1 (2019): 1–18.
   PubMedGoogle Scholar
• Y. H. Zaki, A. R. Sayed, and S. A. Elroby, “Regioselectivity of 1, 3-Dipolar Cycloadditions and Antimicrobial Activity of Isoxazoline, Pyrrolo [3, 4-d] Isoxazole-4, 6-Diones, Pyrazolo [3, 4-d] Pyridazines and Pyrazolo [1, 5-a] Pyrimidines,” Chemistry Central Journal 10, no. 1 (2016): 1–13.
   PubMedGoogle Scholar
• Y. H. Zaki, S. M. Gomha, and A. M. G. Mohamed, “Utility of 2-Thioxo-Pyrido [2, 3-d] Pyrimidinone in Synthesis of Pyridopyrimido [2, 1-b][1, 3, 5]-Thiadiazinones and Pyridopyrimido [2, 1-b][1, 3] Thiazinones as Antimicrobial Agents,” Chemistry Central Journal 11, no. 1 (2017): 1–10.
   PubMedGoogle Scholar
• Mohammed M. S. Wassel, Wael M. Gamal Eldin, Ahmed Ragab, Gameel A. M. Elhag Ali, and Yousry A. Ammar, “Antiviral Activity of Adamantane-Pyrazole Derivatives against Foot and Mouth Disease Virus Infection in Vivo and in Vitro with Molecular Docking Study,” Journal of Applied Veterinary Sciences 5, no. 4 (2020): 37–46.
   Google Scholar
• A. Ragab, S. A. Fouad, O. A. A. Ali, E. M. Ahmed, A. M. Ali, A. A. Askar, and Y. A. Ammar, “Sulfaguanidine Hybrid with Some New Pyridine-2-One Derivatives: Design, Synthesis, and Antimicrobial Activity against Multidrug-Resistant Bacteria as Dual DNA Gyrase and DHFR Inhibitors,” Antibiotics 10, no. 2 (2021): 162.
   Google Scholar
• J. L. Rodríguez-Tudela, F. Barchiesi, J. Bille, E. Chryssanthou, M. Cuenca-Estrella, D. Denning, J. P. Donnelly, B. Dupont, W. Fegeler, C. Moore, et al. “Method for the Determination of Minimum Inhibitory Concentration (MIC) by Broth Dilution of Fermentative Yeasts,” Clinical Microbiology and Infection 9, no. 8 (2003): i–viii.
   Web of Science ®Google Scholar